Newsletter | September 12, 2024

09.12.24 -- Early Planning Trumps eCOA Bells And Whistles

FEATURED EDITORIAL

Early Planning Trumps eCOA Bells And Whistles

Julie Dietrich is a huge advocate for detailed documentation and early planning when it comes to successfully implementing eCOA systems. A good old-fashioned focus group couldn’t hurt either, she says.

INDUSTRY INSIGHTS

Optimal eCOA For Vaccine Trials

Delve into the pivotal role that technologies like electronic Patient-Reported Outcomes (ePRO) can play in generating substantiating evidence and streamlining vaccine trial operations.

Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments

Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.

Site-Centric Clinical Platforms Are Better For Sponsors

Discover how seven of the top 15 global biopharmaceutical companies came together on a single clinical technology platform and operated through common workflows and common trial documents.

Novel Platform For Execution Of Pragmatic Studies Boosts Efficiency

In partnering with Genentech and Foundation Medicine, see how Flatiron was able to develop a novel platform for the execution of pragmatic studies.

The Impact Of Automation In The Monitoring And Reporting Process

As clinical trial costs rise and ROIs decline, research teams are turning to automation to streamline monitoring and reporting processes without compromising data quality or regulatory compliance.

Build Better Studies Faster: 3 Advantages Of Mobile eClinical Platforms

Embrace the digital revolution in clinical research with advanced eClinical platforms that expand reach, enhance efficiency, and streamline processes, revolutionizing your trials and work-life balance.

Fast Data Insights Improve Productivity, Client Centricity

Review this example, where Medidata's Rave CTMS met Catalyst Clinical Research's—an exclusive CRO provider specializing in oncology—requirements amid rapid expansion.